Tcr2 Therapeutics
$1.48
10
-$0.09-5.73% Wednesday 20:00
Statistics
Day High
-
Day Low
-
52W High
-
52W Low
-
Volume
-
Avg. Volume
-
Mkt Cap
57.21M
P/E Ratio
0
Dividend Yield
-
Dividend
-
Earnings
7AugExpected
Expected EPS
-0.63
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-151.82MNet Income
People Also Follow
This list is based on the watchlists of people on Stock Events who follow TCRR. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
About
Pharmaceuticals: Major
Health Technology
Manufacturing
Biological Product (except Diagnostic) Manufacturing
TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, develops novel T cell receptor therapies for patients suffering from cancer. The company's lead product candidates include TC-210, mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which initiated in phase I/II clinical trial for the treatment of non-small cell lung cancer (NSCLC), ovarian cancer, malignant pleural/peritoneal mesothelioma, and cholangiocarcinoma; and TC-110 a TRuC-T cell targeting CD19-positive B-Cell hematological malignancies. Its product candidates in pipeline focuses on adult acute lymphoblastic leukemia, diffuse large B-cell lymphoma, and follicular lymphoma areas. The company was formerly known as TCR2, Inc. and changed its name to TCR2 Therapeutics Inc. in November 2016. TCR2 Therapeutics Inc. was founded in 2015 and is headquartered in Cambridge, Massachusetts.
Show more...
CEO
Garry Menzel
Employees
131
Country
US
ISIN
US87808K1060
WKN
000A2PBHX
Listings
0 Comments
Share your thoughts
FAQ
What is Tcr2 Therapeutics stock price today?▼
The current price of TCRR is $1.48 USD — it has decreased by -5.73% in the past 24 hours. Watch Tcr2 Therapeutics stock price performance more closely on the chart.
What is Tcr2 Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Tcr2 Therapeutics stocks are traded under the ticker TCRR.
What is Tcr2 Therapeutics market cap?▼
Today Tcr2 Therapeutics has the market capitalization of 57.21M
What is Tcr2 Therapeutics revenue for the last year?▼
Tcr2 Therapeutics revenue for the last year amounts to 0 USD.
What is Tcr2 Therapeutics net income for the last year?▼
TCRR net income for the last year is -151.82M USD.
How many employees does Tcr2 Therapeutics have?▼
As of April 02, 2026, the company has 131 employees.
In which sector is Tcr2 Therapeutics located?▼
Tcr2 Therapeutics operates in the Manufacturing sector.
When did Tcr2 Therapeutics complete a stock split?▼
Tcr2 Therapeutics has not had any recent stock splits.
Where is Tcr2 Therapeutics headquartered?▼
Tcr2 Therapeutics is headquartered in Cambridge, US.